Javascript must be enabled to continue!
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
View through CrossRef
The AP-1 transcription factor c-Jun is a key regulator of hepatocyte proliferation. Mice lacking c-Jun in the liver (
c-jun
Δli*
) display impaired liver regeneration after partial hepatectomy (PH). This phenotype correlates with increased protein levels of the cdk-inhibitor p21 in the liver. We performed PH experiments in several double-knockout mouse models to genetically identify the signaling events regulated by c-Jun. Inactivation of
p53
in
c-jun
Δli*
mice abrogated both hepatocyte cell cycle block and increased p21 protein expression. Consistently, liver regeneration was rescued in
c-jun
Δli*
p21
−/−
double-mutant mice. This indicated that c-Jun controls hepatocyte proliferation by a p53/p21-dependent mechanism. Analyses of
p21
mRNA and protein expression in livers of
c-jun
Δli*
mice after PH revealed that the accumulation of p21 protein is due to a post-transcriptional/post-translational mechanism. We have investigated several candidate pathways implicated in the regulation of p21 expression, and observed increased activity of the stress kinase p38 in regenerating livers of
c-jun
Δli*
mice. Importantly, conditional deletion of
p38
α in livers of
c-jun
Δli*
mice fully restored hepatocyte proliferation and attenuated increased p21 protein levels after PH. These data demonstrate that c-Jun/AP-1 regulates liver regeneration through a novel molecular pathway that involves p53, p21, and the stress kinase p38α.
Cold Spring Harbor Laboratory
Title: c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Description:
The AP-1 transcription factor c-Jun is a key regulator of hepatocyte proliferation.
Mice lacking c-Jun in the liver (
c-jun
Δli*
) display impaired liver regeneration after partial hepatectomy (PH).
This phenotype correlates with increased protein levels of the cdk-inhibitor p21 in the liver.
We performed PH experiments in several double-knockout mouse models to genetically identify the signaling events regulated by c-Jun.
Inactivation of
p53
in
c-jun
Δli*
mice abrogated both hepatocyte cell cycle block and increased p21 protein expression.
Consistently, liver regeneration was rescued in
c-jun
Δli*
p21
−/−
double-mutant mice.
This indicated that c-Jun controls hepatocyte proliferation by a p53/p21-dependent mechanism.
Analyses of
p21
mRNA and protein expression in livers of
c-jun
Δli*
mice after PH revealed that the accumulation of p21 protein is due to a post-transcriptional/post-translational mechanism.
We have investigated several candidate pathways implicated in the regulation of p21 expression, and observed increased activity of the stress kinase p38 in regenerating livers of
c-jun
Δli*
mice.
Importantly, conditional deletion of
p38
α in livers of
c-jun
Δli*
mice fully restored hepatocyte proliferation and attenuated increased p21 protein levels after PH.
These data demonstrate that c-Jun/AP-1 regulates liver regeneration through a novel molecular pathway that involves p53, p21, and the stress kinase p38α.
Related Results
Tracking and Inhibiting Atypical Vascular Inflammation
Tracking and Inhibiting Atypical Vascular Inflammation
Mitogen‐activated protein kinase (MAPK) p38 drives the onset and progression of many clinically challenging diseases. However, three decades of research have failed to yield clinic...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract 1706: Investigating the interaction between ETS family members and mutant p53
Abstract
Cancer cases are on the rise globally requiring a deeper understanding of the disease and identification of novel therapeutic targets. Mutations in genes of...
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has ...
STK4 antisense RNA 1-p53 affects osteosarcoma
STK4 antisense RNA 1-p53 affects osteosarcoma
Abstract
Background
LncRNA STK4 antisense RNA 1(STK4-AS1) has been identified as a potential biomarker associated with multiple cancers. We proposed that STK4-AS1 plays a ...
Abstract 1728: Overactivation of tumor suppressor P53 in hepatocytes promotes hepatocarcinogenesis
Abstract 1728: Overactivation of tumor suppressor P53 in hepatocytes promotes hepatocarcinogenesis
Abstract
Aim: p53 is a tumor suppressor and its dysfunction promotes carcinogenesis of several organs including the liver. Meanwhile, p53 is reported to be overac...
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract
Although the main function of p53 is a nuclear transcription factor that has important roles in cell cycle arrest, DNA repair, and apoptosis, p53 can direct...

